| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 111.493.461 $ | 97,69 | 943.803 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 15.592.590 $ | 13,66 | 13.000 | |
| Mettler-Toledo International Inc | Mettler-Toledo International Inc | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 6.387.550 $ | 5,60 | 5.000 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 6.349.250 $ | 5,56 | 25.000 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 4.824.404 $ | 4,23 | 5.200 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 4.462.104 $ | 3,91 | 8.900 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 4.423.750 $ | 3,88 | 125.000 | |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 4.404.400 $ | 3,86 | 130.000 | |
| Welltower Inc | Welltower Inc | EC | 95040Q104 | Long | Börsenkurs (Stufe 1) | 3.858.490 $ | 3,38 | 17.000 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 3.740.670 $ | 3,28 | 9.000 | |
| RadNet Inc | RadNet Inc | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 3.700.200 $ | 3,24 | 60.000 | |
| Billiontoone Inc | Billiontoone Inc | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 3.239.460 $ | 2,84 | 27.000 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 3.012.318 $ | 2,64 | 33.300 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 2.980.380 $ | 2,61 | 6.000 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 2.844.300 $ | 2,49 | 15.000 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 2.827.000 $ | 2,48 | 22.000 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 2.475.495 $ | 2,17 | 16.500 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 2.416.275 $ | 2,12 | 4.500 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 2.341.000 $ | 2,05 | 12.500 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 2.337.950 $ | 2,05 | 95.000 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 2.293.400 $ | 2,01 | 20.000 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 2.274.120 $ | 1,99 | 18.000 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 2.198.745 $ | 1,93 | 8.100 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 1.988.400 $ | 1,74 | 5.000 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.961.280 $ | 1,72 | 16.000 | |
| Elevance Health Inc | Elevance Health Inc | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 1.933.650 $ | 1,69 | 5.000 | |
| Repligen Corp | Repligen Corp | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 1.705.500 $ | 1,49 | 12.500 | |
| Xenon Pharmaceuticals Inc | Xenon Pharmaceuticals Inc | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 1.509.000 $ | 1,32 | 25.000 | |
| HeartFlow Inc | HeartFlow Inc | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 1.433.200 $ | 1,26 | 48.848 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.427.220 $ | 1,25 | 18.000 | |
| IDEXX Laboratories Inc | IDEXX Laboratories Inc | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 1.368.744 $ | 1,20 | 2.600 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 1.347.000 $ | 1,18 | 20.000 | |
| VeraDermics Inc | VeraDermics Inc | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 1.229.400 $ | 1,08 | 10.000 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.066.200 $ | 0,93 | 10.000 | |
| Arcutis Biotherapeutics Inc | Arcutis Biotherapeutics Inc | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 917.700 $ | 0,80 | 35.000 | |
| Sartorius Stedim Biotech | Sartorius Stedim Biotech | EC | FR0013154002 | Long | Modellwert (Stufe 2) | 829.412 $ | 0,73 | 4.000 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 734.310 $ | 0,64 | 3.000 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 724.115 $ | 0,63 | 8.500 | |
| Definium Therapeutics Inc | Definium Therapeutics Inc | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 651.739 $ | 0,57 | 13.855 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 400.080 $ | 0,35 | 1.500 | |
| Tango Therapeutics Inc | Tango Therapeutics Inc | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 390.750 $ | 0,34 | 12.500 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 333.150 $ | 0,29 | 2.500 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 305.010 $ | 0,27 | 9.000 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 253.750 $ | 0,22 | 5.000 | |
| 111.493.461 $ | 97,69 | 943.803 |